DORA PSI | Digital Object Repository at PSI

Export As:

Style

Style

Search Results 1 - 3 of 3

Sort

	Select Page
	Signaling network response to <em>α</em>-particle–targeted therapy with the <sup>225</sup>Ac-labeled minigastrin analog <sup>225</sup>Ac-PP-F11N reveals the radiosensitizing potential of histone deacetylase inhibitors Qin, Y., Imobersteg, S., Frank, S., Blanc, A., Chiorazzo, T., Berger, P., … Grzmil, M. (2023). Signaling network response to α-particle–targeted therapy with the ²²⁵Ac-labeled minigastrin analog ²²⁵Ac-PP-F11N reveals the radiosensitizing potential of histone deacetylase inhibitors. Journal of Nuclear Medicine, 64(6), 873-879. https://doi.org/10.2967/jnumed.122.264597 Detailed Record Published Version
	Pharmacological inhibition of mTORC1 increases CCKBR-specific tumor uptake of radiolabeled minigastrin analogue [<sup>177</sup>Lu]Lu-PP-F11N Grzmil, M., Qin, Y., Schleuniger, C., Frank, S., Imobersteg, S., Blanc, A., … Behe, M. (2020). Pharmacological inhibition of mTORC1 increases CCKBR-specific tumor uptake of radiolabeled minigastrin analogue [¹⁷⁷Lu]Lu-PP-F11N. Theranostics, 10(24), 10861-10873. https://doi.org/10.7150/thno.45440 Detailed Record Published Version
	Evaluation of actinium-225 labeled minigastrin analogue [<sup>225</sup>Ac]Ac-DOTA-PP-F11N for targeted alpha particle therapy Qin, Y., Imobersteg, S., Blanc, A., Frank, S., Schibli, R., Béhé, M. P., & Grzmil, M. (2020). Evaluation of actinium-225 labeled minigastrin analogue [²²⁵Ac]Ac-DOTA-PP-F11N for targeted alpha particle therapy. Pharmaceutics, 12(11), 1088 (12 pp.). https://doi.org/10.3390/pharmaceutics12111088 Detailed Record Published Version